LUSDUNA

This brand name is authorized in Estonia, Lithuania

Active ingredients

The drug LUSDUNA contains one active pharmaceutical ingredient (API):

1 Insulin glargine
UNII 2ZM8CX04RZ - INSULIN GLARGINE

Insulin glargine is a human insulin analogue designed to have a low solubility at neutral pH. After injection, the acidic solution is neutralised leading to formation of a precipitate from which small amounts of insulin glargine are continuously released.

Read about Insulin glargine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A10AE04 Insulin glargine A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AE Insulins and analogues for injection, long-acting
Discover more medicines within A10AE04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1736344, 1736355, 1736366
Country: LT Valstybinฤ— vaistลณ kontrolฤ—s tarnyba Identifier(s): 1081977, 1081978, 1081979

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈